Investor's Business Daily on MSN27m
Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter ReportTeva stock jumped early Wednesday after the drugmaker reported adjusted earnings of 69 per share on $4.33 billion in third-quarter sales.Please watch the video at Investors.com - How Novo Nordisk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback